SearchDictionaryMobileLogin

Pharmacokinetics of once-daily tenofovir, emtricitabine, ritonavir and fosamprenavir in HIV-infected subjects.

AbstractHAART has decreased the incidence of AIDS and death among HIV-infected individuals dramatically. This approach often becomes cumbersome to patients, involving multiple drugs administered on varying schedules. We investigated the pharmacokinetics, efficacy, and tolerability of a once-daily regimen of fosamprenavir, tenofovir, emtricitabine and ritonavir in HIV-infected treatment-naive subjects. No clinically significant interaction between the drugs was noted, and the regimen showed good efficacy and tolerability over the course of 48 weeks.
AuthorsDavid A Parks, Harold C Jennings, Christopher W Taylor, Edward P Acosta (Affiliation: Central West Clinical Research, St Louis, Missouri, USA.)
JournalAIDS (London, England) (AIDS) Vol. 21 Issue 10 Pg. 1373-5 (Jun 19 2007) ISSN: 0269-9370 England
PMID17545719 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • Carbamates
  • HIV Protease Inhibitors
  • Phosphonic Acids
  • Phosphoric Acid Esters
  • RNA, Viral
  • Reverse Transcriptase Inhibitors
  • Ritonavir
  • Sulfonamides
  • emtricitabine
  • fosamprenavir
  • tenofovir disoproxil
  • Adenine
  • Deoxycytidine
Topics
  • Adenine (administration & dosage, analogs & derivatives, blood, pharmacokinetics)
  • Adolescent
  • Adult
  • Antiviral Agents (administration & dosage, blood, pharmacokinetics)
  • Carbamates (administration & dosage, blood, pharmacokinetics)
  • Deoxycytidine (administration & dosage, analogs & derivatives, blood, pharmacokinetics)
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • HIV Infections (blood, drug therapy)
  • HIV Protease Inhibitors (administration & dosage, blood, pharmacokinetics)
  • Humans
  • Phosphonic Acids (administration & dosage, blood, pharmacokinetics)
  • Phosphoric Acid Esters (administration & dosage, blood, pharmacokinetics)
  • RNA, Viral (analysis)
  • Reverse Transcriptase Inhibitors (administration & dosage, blood, pharmacokinetics)
  • Ritonavir (administration & dosage, blood, pharmacokinetics)
  • Sulfonamides (administration & dosage, blood, pharmacokinetics)
  • Treatment Outcome